Document is current
Any future updates will be listed below
-
Authors
Farley, Clara
Bassett, Roland
Meric-Bernstam, Funda
Bedrosian, Isabelle
Caudle, Abigail
DeSnyder, Sarah
Hunt, Kelly
Kuerer, Henry
Singh, Puneet
Sun, Susie
Tamirisa, Nina
Teshome, Mediget
Hwang, Rosa F.
-
Funding
Funding for this research was provided by:
Division of Cancer Prevention, National Cancer Institute (award number P30 CA016672)
- License Information
-
More Information
Article History
Received: 13 July 2023
Accepted: 17 August 2023
First Online: 5 September 2023
Disclosure
: Kelly K. Hunt—Medical Advisory Board (AstraZeneca and ArmadaHealth); Research funding to institution (Cairn Surgical, Eli Lilly & Co., Lumicell). Funda Meric-Bernstam. Consulting: AbbVie, Aduro BioTech Inc., Alkermes, AstraZeneca, Daiichi Sankyo Co. Ltd., Calibr (a division of Scripps Research), DebioPharm, Ecor1 Capital, eFFECTOR Therapeutics, F. Hoffman-La Roche Ltd., GT Apeiron, Genentech Inc., Harbinger Health, IBM Watson, Infinity Pharmaceuticals, Jackson Laboratory, Kolon Life Science, Lengo Therapeutics, Menarini Group, OrigiMed, PACT Pharma, Parexel International, Pfizer Inc., Protai Bio Ltd, Samsung Bioepis, Seattle Genetics Inc., Tallac Therapeutics, Tyra Biosciences, Xencor, Zymeworks. Advisory Committee: Black Diamond, Biovica, Eisai, FogPharma, Immunomedics, Inflection Biosciences, Karyopharm Therapeutics, Loxo Oncology, Mersana Therapeutics, OnCusp Therapeutics, Puma Biotechnology Inc., Seattle Genetics, Sanofi, Silverback Therapeutics, Spectrum Pharmaceuticals, Theratechnologies, Zentalis. Sponsored Research (to the institution). Aileron Therapeutics, Inc. AstraZeneca, Bayer Healthcare Pharmaceutical, Calithera Biosciences Inc., Curis Inc., CytomX Therapeutics Inc., Daiichi Sankyo Co. Ltd., Debiopharm International, eFFECTOR Therapeutics, Genentech Inc., Guardant Health Inc., Klus Pharma, Takeda Pharmaceutical, Novartis, Puma Biotechnology Inc., Taiho Pharmaceutical Co. Other (Travel Related). European Organisation for Research and Treatment of Cancer (EORTC), European Society for Medical Oncology (ESMO), Cholangiocarcinoma Foundation. Mediget Teshome: Endomag—travel and accommodations to conference in 14 November 2022. Rosa Hwang: Intuitive Surgical Inc.–support for clinical trial received for institution. Stellanova Therapeutics—member, Scientific Advisory Board. All other authors have reported no financial disclosures.
